3.09

1.28% -0.04

After Hours: 3.09

Embecta Corp (EMBC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Embecta Corp stock is traded at $3.09, with a volume of 2.15M. It is down -1.28% in the last 24 hours and down -1.59% over the past month. Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Previous Close:

$3.13

Open:

$3.13

24h Volume:

2.15M

Relative Volume:

1.13

Market Cap:

$183.32M

Revenue:

$1.04B

Net Income/Loss:

$111.90M

P/E Ratio:

1.5684

EPS:

1.9701

Net Cash Flow:

$205.80M

1W Performance:

-6.65%

1M Performance:

-1.59%

6M Performance:

-74.01%

1Y Performance:

-69.22%

1-Day Range:

$3.05

$3.27

1-Week Range:

$3.02

$3.32

52-Week Range:

$2.77

$15.55

Embecta Corp Stock (EMBC) Company Profile

Name

Embecta Corp

Sector

Healthcare (1107)

Industry

Medical Instruments & Supplies (56)

Phone

(862) 401-0000

Address

300 KIMBALL DRIVE, PARSIPPANY

Employee

1,850

Twitter

Next Earnings Date

2026-05-05

Latest SEC Filings

EMBC's Discussions on Twitter

Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EMBC Embecta Corp	3.09	185.70M	1.04B	111.90M	205.80M	1.9701
ISRG Intuitive Surgical Inc	417.07	147.53B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	145.16	40.10B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	65.84	32.33B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	37.09	31.57B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	193.94	27.96B	5.54B	1.52B	1.74B	10.37

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-10-25	Initiated	Mizuho	Neutral
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight
Jun-21-22	Initiated	BofA Securities	Underperform

View All

Embecta Corp Stock (EMBC) Latest News

Jun 16, 2026

Embecta Corp. Announces Appointment of Nimish Muzumdar to Senior Vice President and President, North America, Effective June 15, 2026 - marketscreener.com

Jun 16, 2026

Embecta Corp. Appoints Nimish Muzumdar as Senior Vice President and President, North America - Quiver Quantitative

Jun 16, 2026

New embecta North America chief once ran a $1B generics division - Stock Titan

Jun 16, 2026

Jun 15, 2026

EMBC Investors Have Opportunity to Join Embecta Corp. Fraud Investigation with the Schall Law Firm - The AI Journal

Jun 15, 2026

Jun 12, 2026

EMBC News | EMBECTA CORP (NASDAQ:EMBC) - ChartMill

Jun 12, 2026

Jun 11, 2026

Packaging update regarding BD pen needles and insulin syringes - retailpharmacymagazine.com.au

Jun 11, 2026

EMBC Q1 2026 Earnings: EPS Miss Sends Shares LowerEarnings Sentiment Score - newsline.com

Jun 11, 2026

Jun 08, 2026

EMBC Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesEPS Surprise History - newsline.com

Jun 08, 2026

Jun 06, 2026

EMBC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 06, 2026

Jun 05, 2026